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SwitzerlandAbstractWe report the selection in a 15-year-old boy of a multidrug-
resistant, extended-spectrum β-lactamase (ESBL)-producing
Aeromonas salmonicida after medicinal leech therapy that required
an antibiotic prophylaxis based on piperacillin/tazobactam and
cotrimoxazole. Whole genome sequencing of the strain indeed
revealed 13 antibiotic resistance genes, including the ESBL CTX-
M-3 and the unusual β-lactamase SCO-1.
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E-mail: etienne.ruppe@gmail.comIntroductionOur patient was a healthy 15-year-old boy who experienced
traumatic proximal phalange avulsion of his left (nondominant)This is an open access artithumb. The ﬁnger was immediately reimplanted with success. Six
days later, however, he sought care for acute ischaemia and
underwent repeat exploration that identiﬁed complete arterial
and venous thrombosis. For the venous congestion, medicinal
leech therapy (MLT, also referred as hirudotherapy; Fig. 1) was
initiated (9 February 2016, referred as day 0; Table 1).
Concomitantly, because of surgery and the infectious risk of
MLT, piperacillin/tazobactam-based prophylaxis was initiated,
and a sample of the leech conservation medium (tap water) was
sent at day 8 for culture to the bacteriology laboratory. It yielded
Acinetobacter johnsonii, Aeromonas veronii and Moraxella osloensis,
all identiﬁed by matrix-assisted desorption ionization–time of
ﬂight mass spectrometry (MALDI-TOF MS) (MALDI Biotyper;
Bruker Daltonics, Bremen, Germany; database version 3.1) and
displaying a wild-type susceptibility to antibiotics (Table 1). MLT
was successfully conducted for 14 dayswhile the patient received
piperacillin/tazobactam prophylaxis. Various wound swabs were
sent for culture, which yielded Stenotrophomonas maltophilia and
Aeromonas sp. that remained susceptible to β-lactams. No in-
fectious complication was seen. Prophylaxis with cotrimoxazole
was provided for 3 days after MLT ended (from day 13 to day 15).
At day 26, a multidrug-resistant Aeromonas salmonicida (named
ASG1) was recovered from the wound after culture on blood-
supplemented agar plate under aerobic conditions at 35°C and
identiﬁcation by MALDI-TOFMS. The phenotypic traits of ASG1
are shown in the Supplementary Table S1. Of note, no sign of
surgical site infection was observed, and the presence of ASG1
was considered to be colonization. Accordingly, no antibiotic
treatment was initiated. Another sample of the wound taken at
day 35 yielded S. maltophilia but not A. salmonicida (Table 1).
The strain ASG1 displayed a phenotype compatible with the
production of an extended-spectrum β-lactamase (ESBL) ac-
cording to the double-disk synergy test and was resistant to all
the tested β-lactams except imipenem (minimal inhibitory
concentration (MIC) 0.38 mg/L) and meropenem (MIC 0.5 mg/L).
Moreover, the strain was resistant to ciproﬂoxacin, gentamicin
and cotrimoxazole, while it was susceptible to amikacin, fos-
fomycin, tigecycline and colistin (MIC 0.25 mg/L). Because of
this atypical resistance proﬁle, the genome of the strain was
sequenced. Patient consent for reporting the case was obtained
on 2 November 2016.Genome AnalysisGenomic DNA was extracted using the MagCore Genomic
DNA Tissue Kit (RBC Bioscience, New Taipei City, Taiwan)
and was sent to Fasteris (Plan-les-Ouates, Switzerland) for
sequencing. The library was prepared using the Nextera XTNew Microbe and New Infect 2018; 21: 23–27
© 2017 The Authors. Published by Elsevier Ltd
cle under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
https://doi.org/10.1016/j.nmni.2017.10.005
FIG. 1. Leeches on replanted left thumb. Note use of plastic cup to
target treatment on distal phalanx and prevent leeches from escaping
area requiring treatment. Perforated lid is used to close cup. Consent
from patient’s representative for using pictures was obtained on 2
November 2016.
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24 New Microbes and New Infections, Volume 21 Number C, January 2018 NMNIDNA Sample Preparation Kit according to the Illumina (San
Diego, CA, USA) instructions, and was sequenced on an Illu-
mina MiSeq with 250 bp paired-end reads. The Trimmomatic
package [1] was used to remove bases that corresponded to
the standard Illumina adapters. A total of 208 982 cleaned reads
were obtained (sequence read archive no. PRJNA377399). The
reads were assembled with IDBA-UD [2], yielding 150 contigs
(the largest contig being 215 626 bp, N50 74 kbp) for a total
length of 4 971 056 bp. The median depth of sequencing was
16×. Using JSpeciesWS [3], the average nucleotidic identity
(ANI) with A. salmonicida type strain ATCC 33658 was 97.0%
(range of ANI with other A. salmonicida genomes 96.7–97.2%,
Supplementary Table S2). The mean ANI with other Aeromonas
species for which genomes are available was 83.8% (range
76.8–90.4%, Supplementary Table S2). The alignment of the
16S rRNA sequence of ASG1 together with those of other
Aeromonas species showed that ASG1 clustered with
A. salmonicida (Fig. 2). The genes were predicted and annotated
with PROKKA [6]. We aligned the amino acid sequences of the
topoisomerases (GyrA, GyrB, ParC and ParE) of ASG1 with those
of the reference strain A449 and found the Ser83Ile (GyrA) and
the Glu93Lys (ParC) mutations that likely conferred the cipro-
ﬂoxacin resistance observed in ASG1. The antibiotic resistance
determinants (ARDs) were searched using BLASTP [7] using
the ResFinder [8] and ResFinderFG (https://cge.cbs.dtu.dk/servi
ces/ResFinderFG/) databases and a cutoff of 80% amino acid
identity over 80% of the reference sequence. We found 13
ARDs. Aside from the intrinsic FOX, CphA and OXA-12-like
β-lactamases found in Aeromonas spp. [9], we identiﬁed the
CTX-M-3 ESBL, TEM-1 and—more surprisingly—the SCO-1
inhibitor–resistant class A β-lactamase, all of which, taken© 2017 The Authors. Published by Elsevier Ltd, NMNI, 21, 23–27
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
FIG. 2. Phylogenetic tree of 16S rRNA gene sequences encoding genes of Aeromonas species strain ASG1 and of Tolumonas auensis DSM_9187
(member of Aeromonadaceae family) to root tree. Tree was built using maximum likelihood (PhyML [4]) and iTOL online tool [5].
NMNI Ruppé et al. Multidrug-resistant Aeromonas salmonicida 25together, likely explain the resistance to piperacillin/tazobactam.
Using the plasmid-SPAdes assembler [24], we obtained a 21 555
bp contig containing the blaSCO-1, blaCTX-M-3, blaTEM-1 and aac(3)-
II (conferring resistance to gentamicin) genes, together with
genes associated with DNA mobility (Supplementary Fig. S1),
supporting the location of blaSCO-1 on a mobile genetic element.
We also found the aminoglycoside-modifying enzymes APH(30)-
Ia (resistance to kanamycin) and Aad(A2) (resistance to strep-
tomycin). Eventually the Sul and DfrA12 encoding genes (which
confer resistance to cotrimoxazole, which the patient received
for 3 days after the cessation of MLT), the Tet(E) encoding gene
(resistance to tetracyclines) and the CatA2 encoding gene
(resistance to chloramphenicol) were identiﬁed. The search for
plasmid replicons using PlasmidFinder [10] returned negative for
contigs obtained with both IDBA-UD and plasmid-SPAdes.DiscussionAeromonas spp. are natural colonizers of the digestive tract of
leeches. Hence, since MLT has been used, the risk of infectionsThis is an open access articdue to Aeromonas sp. has been raised [11]. Accordingly, antibiotic
prophylaxis, supplementation of the leech conservation medium
with antibiotics or both has been proposed [12]. While infection
with ciproﬂoxacin-resistant Aeromonas hydrophila during MLT
has been reported [13], most Aeromonas strains appear to be
susceptible to third-generation cephalosporins and piperacillin/
tazobactam in this context [14]. In addition, several cases of in-
fections due to ESBL (including CTX-M)-producing Aeromonas
have been reported, but not in connection with MLT [15,16].
In our case, ASG1 was likely selected by the exposure to
piperacillin/tazobactam and cotrimoxazole. The origin of ASG1
and of its acquired ARDs remains unknown because no other
resistant strain was recovered from wound cultures. One
possibility is that the plasmid could have been transferred from
a transient bacterium from blood. Arguments against this hy-
pothesis are that a rectal swab performed in the patient at day
38 was negative for any ESBL-producing Enterobacteriaceae, and
the patient did not show any clinical sign of bacteraemia.
Another possibility is that the water in which the leeches were
bathed could have been contaminated either by ASG1 or
another strain that could have transferred the SCO-1 plasmid© 2017 The Authors. Published by Elsevier Ltd, NMNI, 21, 23–27
le under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
26 New Microbes and New Infections, Volume 21 Number C, January 2018 NMNIto ASG1. Nonetheless, other Aeromonas strains have been
recovered from the leech conservation medium and from the
wound, but neither ASG1 nor another A. salmonicida strain was
identiﬁed. Possibly they may have been outnumbered by other
bacteria. However, we are conﬁdent that the Aeromonas sp.
strain isolated at day 20 and ASG1 was distinct, ﬁrstly because
of their high MALDI-TOF MS scores (2.348 for Aeromonas sp.,
2.154 for A. salmonicida strain ASG1), and secondly because of
the different antibiotic resistance proﬁles, especially for ﬂuo-
roquinolones (which is driven by the two chromosomal mu-
tations found in the topoisomerases of ASG1, while the
Aeromonas sp. strain was susceptible to ﬂuoroquinolones).
Even more surprising is the presence of SCO-1, a carbeni-
cillinase that has rarely been reported [17–20]. The production
of SCO-1 confers resistance to penicillins and to their combi-
nation with clavulanate but modestly decreases the suscepti-
bility to piperacillin/tazobactam [18,19]. Of note, the genetic
neighbourhood of blaSCO-1 was found to be similar to that of
previous reports [17–20], being inconsistent with a new
mobilization of blaSCO-1. The original host of SCO-1 remains
unknown. Interestingly, as of this writing, SCO-1 is not included
in the popular ResFinder [8] and CARD [21] databases, while it
is in ARG-ANNOT [22] and MEGARes [23].
In conclusion, our observation suggests that antibiotic
exposure can select for multidrug-resistant Aeromonas spp.
during MLT, which warrants surveillance of the emergence of
resistance during MLT.Conﬂict of InterestNone declared.Appendix A. Supplementary dataSupplementary data related to this article can be found at
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